Dual role of the bile acid receptor Takeda G‐protein‐coupled receptor 5 for hepatic lipid metabolism in feast and famine
Dieter Häussinger, Verena Keitel – 27 December 2016
Inhibition of the sterol regulatory element‐binding protein pathway suppresses hepatocellular carcinoma by repressing inflammation in mice
Na Li, Zhang‐Sen Zhou, Yang Shen, Jie Xu, Hong‐Hua Miao, Ying Xiong, Feng Xu, Bo‐Liang Li, Jie Luo, Bao‐Liang Song – 27 December 2016 – Obesity is a critical risk factor for hepatocellular carcinoma (HCC). However, it remains unknown whether inhibition of de novo lipid biosynthesis can suppress HCC.
TM6SF2 rs58542926 impacts lipid processing in liver and small intestine
Elizabeth A. O'Hare, Rongze Yang, Laura M. Yerges‐Armstrong, Urmila Sreenivasan, Rebecca McFarland, Carmen C. Leitch, Meredith H. Wilson, Shilpa Narina, Alexis Gorden, Kathy A. Ryan, Alan R. Shuldiner, Steve A. Farber, G. Craig Wood, Christopher D. Still, Glenn S. Gerhard, Janet D. Robishaw, Carole Sztalryd, Norann A.
Reply
Tammy T. Chang – 27 December 2016
Instructions to authors and Information for readers
27 December 2016
Reply
Jenny Yeuk‐Ki Cheng, Yee‐Kit Tse, Grace Lai‐Hung Wong – 23 December 2016
Effect of metabolic syndrome on cardiovascular, hepatic events, and death in chronic hepatitis B patients: Methodological issues
Erfan Ayubi, Saeid Safiri, Mohadeseh Sani, Amin Doosti‐Irani, Ali Sanjari Moghaddam – 23 December 2016
Reply:
Gordon D. McLaren, James C. Barton, Grant A. Ramm, Mary J. Emond, V. Nathan Subramaniam, Pradyumna D. Phatak, Paul C. Adams, Lawrie W. Powell, Lyle C. Gurrin, Gregory J. Anderson, Christine E. McLaren – 23 December 2016
Aspirin for cholangiocarcinoma prevention: New targets to shift the dogma from ascertained risk to possible prevention
Giovanni Brandi, Stefania De Lorenzo, Andrea Palloni, Guido Biasco, Francesco Tovoli – 23 December 2016
Liver transplantation for hepatocellular carcinoma through the lens of transplant benefit
Umberto Cillo, Alessandro Vitale, Marina Polacco, Elisa Fasolo – 23 December 2016